RNA Stock 12 Month Analyst Forecast
Eps Overview
Consensus Rating
Consensus Price Target
Highest Price Target
$96.00
31.96% Upside
Mean Price Target
$68.03
-6.49% Downside
Lowest Price Target
$48.00
-34.02% Downside
Recent Analyst Ratings
Upgrades, Downgrades, New Coverage
Actual EPS vs Estimated EPS
RNA Earnings Per Share (EPS) History
According to financial reports, RNA (NYSE: RNA) reported an actual EPS of $-1.27 for the quarter ending on Nov 10, 2025, compared to an estimated $-1.05, resulting in a 20.95% surprise. In the prior quarter (Aug 07, 2025), RNA recorded an actual EPS of $-1.21 with a 27.37% surprise. See RNA's full earnings history.
Earnings History
EPS Surprise Factor Analysis
RNA has experienced notable EPS surprises, with the latest quarter ending Nov 10, 2025 showing a 20.95% beat. Previously, the quarter ending Aug 07, 2025 recorded a 27.37% beat. An EPS surprise factor indicates how much actual earnings deviate from analyst forecasts.
| Report Date | Actual | Forecast | Surprise Factor |
|---|---|---|---|
| Nov 10, 2025 | -1.27 | -1.05 | +20.95% |
| Aug 07, 2025 | -1.21 | -0.95 | +27.37% |
| May 08, 2025 | -0.9 | -0.88 | +2.27% |
| Feb 27, 2025 | -0.8 | -0.76 | +5.26% |
| Nov 07, 2024 | -0.65 | -0.71 | -8.45% |
| Aug 09, 2024 | -0.65 | -0.76 | -14.47% |

